Reminiscent of the Pink Pussycat Sensual Enhancement Pill sold by Pink Toyz
CHATSWORTH, Calif., April 1, 2022 /PRNewswire-PRWeb/ — F&S Medical Supply, dba Pink Toyz is voluntarily recalling one lot of Pink Pussycat 3000mg capsules at the consumer level. FDA analysis found Pink Pussycat product was contaminated with sildenafil, an ingredient known as a phosphodiesterase (PDE-5) inhibitor found in an FDA-approved product for the treatment of dysfunction male erectile. The presence of sildenafil in Pink Pussycat capsules makes the product an unapproved drug for which safety and efficacy have not been established and therefore subject to recall.
Risk Statement: Consumers with underlying health conditions who take Pink Pussycat with undeclared sildenafil may pose serious health risks. For example, PDE-5 inhibitors can interact with nitrates found in some prescription medications (such as nitroglycerin) by lowering blood pressure to dangerous, potentially life-threatening levels. Consumers with diabetes, high blood pressure, or heart disease often take nitrates. As of today, 03/30/2022, Pink Toyz has received no reports of adverse events related to this recall.
The product is marketed as a dietary supplement for male sexual enhancement and is packaged in blister packs of 1 unit, UPC [8 91875 00462 6]. The affected Pink Pussycat lot includes LOT # 2009066 and expiry date 09/2023 which was sold only by Pink Toyz. The product can be identified by the Pink Pussycat Sensual Enhancement capsule. Pink Pussycat was distributed nationwide at Walmart markets.
Pink Toyz is notifying its distributors and customers via email and arranging for the return or destruction of all recalled products.
Consumers who have Pink Pussycat capsules that are subject to a recall should throw them away and request a full refund from where they placed the order.
Consumers with questions regarding this recall may contact Pink Toyz at 747-202-3335 or [email protected] Monday through Friday beginning 04/01/2022, 9:00 a.m. to 5:00 p.m. PST. Consumers should contact their doctor or health care provider if they have experienced any problems that may be related to taking or using this medication.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch adverse event reporting program either online, by regular mail, or by fax.
This recall is being conducted with the knowledge of the United States Food and Drug Administration.
Sina FaghaniF&S Medical Supply Inc, 1 7472023335, [email protected]
SOURCE F & S Medical Supplies Inc